Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis.

Franco-Trepat, Eloi; Guillán-Fresco, María; Alonso-Pérez, Ana; Jorge-Mora, Alberto; Francisco, Vera; Gualillo, Oreste; Gómez, Rodolfo

Franco-Trepat, Eloi; Guillán-Fresco, María; Alonso-Pérez, Ana; Jorge-Mora, Alberto; Francisco, Vera; Gualillo, Oreste; Gómez, Rodolfo.

Afiliação

Franco-Trepat E; Musculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.
Guillán-Fresco M; Musculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.
Alonso-Pérez A; Musculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.
Jorge-Mora A; Musculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.
Francisco V; Research laboratory 9, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.
Gualillo O; Research laboratory 9, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain.
Gómez R; Musculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, SERGAS, 15706 Santiago de Compostela, Spain. rodolfobahamonde@gmail.com.

J Clin Med ; 8(8)2019 Aug 07.

Article em En | MEDLINE | ID: mdl-31394795

Palavras-chave

NAMPT; TLR4; bone; cartilage; catabolism; inflammation; metabolic alterations; osteoarthritis; osteoporosis; visfatin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google